Trial Profile
A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate (Primary) ; Loteprednol etabonate/tobramycin (Primary)
- Indications Ophthalmic infections
- Focus Adverse reactions
- 23 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2009 New trial record